Dr. June Choon Wai Yee

ALTTEXTGOESHERE

Contact Details

B.Pharm(Hons), PhD, Registered Pharmacist (Malaysia)
Lecturer

Office: Building 2, Level 5, Room 43
Tel: +603 5514 4419
Fax: +603 5514 6364
Email: choon.wai.yee@monash.edu

Biodata

Dr June Choon Wai Yee completed her BPharm (Hons) at Universiti Sains Malaysia in 2006 and thereafter her PhD in 2012. She underwent training as a pharmacist at Sungai Buloh Hospital from 2006 to 2007. Dr Choon was actively involved in various researches in biopharmaceutics and bioequivalence studies for over 20 pharmaceutical companies. She sat on the Joint Ethics Committee of the School of Pharmaceutical Sciences, USM-Hospital Lam Wah Ee on human clinical studies from 2008 - 2012.

From 2007 to 2009, Dr Choon also served as Hon. Secretary and Hon. Treasurer for the Penang Chapter of the Malaysian Pharmaceutical Society (MPS). Dr Choon joined Monash as a Lecturer in December 2014. She was also appointed as the Chair of the Organizing Committee for the very successful annual Monash Health Economics Forum for two consecutive years in 2015 and 2016. The annual event is co-organised by the Pharmaceutical Services Division, Ministry of Health Malaysia and also the Pharmaceutical Association of Malaysia (PhAMA), with strong support from industrial partners. Under Dr Choon's leadership, the Forum has since progressed and established itself as one of the most anticipated events on the local pharmaceutical industry calendar. With her keen interest and passion in continuous education, Dr Choon is also currently completing her final stages of her training in Health Economics with the Department of Economics and Related Studies, The University of York.

Areas of Expertise

  1. Health Economics
  2. Clinical pharmacokinetics
  3. Biopharmaceutic studies

Academic Qualifications

Doctor of Philosophy (PhD)
InstitutionUniversiti Sains Malaysia
Year Awarded2012
 
Bachelor of Pharmacy (Hons)
InstitutionUniversiti Sains Malaysia                             
Year Awarded2006

(A) SCHOLARLY JOURNALS (REFEREED ONLY)

Safety and efficacy of health supplement for weight Loss. Ibrahim S, Yee JC, Gupta M, Murugiah MK, Ming LC, Arch Pharma Pract 2016;7:S11-5.
Evidence of Garcinia cambogia as a fat burning and appetite suppressing agents. Ab Rahman WA, Lee KS, Yee JC, Gupta M, Ming LC. Arch Pharma Pract 2016;7:S22-8.
A review of Panax ginseng as an herbal medicine. Nuri TH, Yee JC, Gupta M, Khan MA, Ming LC. Arch Pharma Pract 2016;7:S61-5.
Use of Generic Medicines: Perspectives of consumers living in urban and suburban areas of Klang Valley in Malaysia. Ali SA, Manan MM, Hassali MA, Kassab YW, Choon WY and Masri MB. Journal of Medical Marketing, Vol 13, Issue 4, Nov 2013 pp. 242 – 250
Harm Reduction Program and Methadone Poisoning: Implications for Pediatric Public Health in Malaysia, Journal of Pharmacy Practice 19;5:1-2, 2006

(B) CONFERENCE PROCEEDINGS (REFEREED ONLY)

Outcomes Prediction Using a Generalized Linear Model in a Cohort of Schizophrenic Patients Receiving Paliperidone Long Acting Injectable Treatment in Hong Kong. Choon JWY, Wu DBC, Tomlinson B, Hu M, Chung WS, Lee SC, Lee VWY, Lee KKC. International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 19th Annual European Congress, Vienna, Austria 2016.
A Preliminary Analysis of Health Care Resource Utilization of Paliperidone Palmitate in the Treatment of Schizophrenia in the Public Health Care Sector of Hong Kong. Choon JWY, Wu DBC, Tomlinson B, Hu M, Chung WS, Lee SC, Lee VWY, Lee KKC. International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting, Washington, DC USA. 2016
Antibiotic Prescription Practice For Severe Community-Acquired Pneumonia in the ICU, 10th Malaysian Thoracic

(C) OTHERS (NON-REFEREED PUBLICATIONS INCLUDED)

Insight on Generic medicines and Bioequivalence, Pharmacy Practice, Pharmacy Today (MIMS Pharmacy), Oct 2015 issue

Local Grants

TitleNeuroprotection by Tocotrienols in Type 1 and Type 2 Diabetes Mellitus (VENUS)
InvestigatorsProf Yuen Kah Hay, Dr June Choon
Funding (Start & End Year)2010-2015
Funding Body/OrganisationPEMANDU
Funding AmountRM3,000,000
 
TitleDapagliflozin budget impact analysis model and final budget impact analysis report.
InvestigatorsProf Kenneth Lee, Dr David Wu, Dr June Choon
Funding (Start & End Year)2016-2017
Funding Body/OrganisationAstraZeneca Sdn Bhd
Funding AmountRM46,948
 
TitleProposal for study to assess budget impact of Secukinumab in psoriasis, psoriatic arthritis and anklylosing spondylitis in the public sector of Malaysia.
InvestigatorsProf Kenneth Lee, Dr David Wu, Dr June Choon
Funding (Start & End Year)2016-2017
Funding Body/OrganisationNovartis Corp (Malaysia) Sdn Bhd
Funding AmountRM75,000
 

International Grants

TitleHealth care utilization analysis of Paliperidone palmitate in the treatment of Schizophrenia in the public health care sector of Hong Kong
InvestigatorsProf Kenneth Lee, Dr David Wu, Dr June Choon
Funding (Start & End Year)2014-current
Funding Body/Organisation                                 Janssen Pharmaceuticals (HK) 
Funding AmountHKD250,000
 
TitleThe analysis and publication of Health Economics data for Dapagliflozin in Hong Kong.
InvestigatorsProf Kenneth Lee, Dr David Wu, Dr June Choon
Funding (Start & End Year)2014-2017
Funding Body/OrganisationAstraZeneca Hong Kong Ltd
Funding AmountHKD260,000
 
TitleCost effectiveness of Edoxaban in Patients with non-valvular atrial fibrillation and venous thromboembolism in Hong Kong.
InvestigatorsProf Kenneth Lee, Dr David Wu, Dr June Choon
Funding (Start & End Year)2016-2018
Funding Body/OrganisationDaiichi Sankyo Hong Kong Ltd
Funding AmountHKD240,000

Membership in Academic Editorial Committees

Name of Association/International BodyValue in Health (Regional Issues)
RoleReview
Duration of membership - Month/Year2014 - current
 
Name of Association/International BodyInternational Journal of Marketing Studies
RoleReviewer
Duration of membership - Month/Year2013 - current
 
Name of Association/International BodyJournal of Pharmaceutical Policy and Practice
RoleReviewer
Duration of membership - Month/Year2015 - current
 

Membership in International Professional Bodies

Name of Association/International BodyInternational Society For Pharmacoeconomics and Outcomes Research
RoleMember
Duration of membership - Month/Year2016 - current